Use of robot-assisted vs. open radical cystectomy led to a significantly increased number of days alive and out of the hospital among patients with nonmetastatic bladder cancer. Perspective from David ...

Robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy resulted in a median of 82 vs 80 days alive and out of the hospital within 90 days of surgery. While ...

A 30-day course of prophylactic antibiotics following robot-assisted radical cystectomy significantly reduces the incidence of urinary tract infections (UTIs) and related complications, researchers ...

Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis. The optimal duration of antibiotic prophylaxis is still unknown.

"We found CKD to be independently associated with a higher likelihood of nonorgan confined disease and lymph node metastases as well as postoperative transfusion and 90-day readmissions." – Nguyen, et ...

A recent study reveals comparable outcomes for radical cystectomy and bladder-sparing therapy in treating recurrent ...

Toni Carlos, second from left, is enjoying an active life despite removal of her bladder in 2021 due to bladder cancer. In spring 2022, she celebrated her son Ryan’s high school graduation along with ...

The HUGO robotic-assisted surgery system showed a high surgical success rate and favorable rates of grade 3 complications. The Hugo™ robotic-assisted surgery (RAS) system is safe and effective, ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s IMFINZI ® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after ...

Imfinzi and chemotherapy before surgery, followed by Imfinzi after surgery, generated survival benefits in cisplatin-eligible muscle-invasive bladder cancer. Patients with cisplatin-eligible ...